T 2307

Drug Profile

T 2307

Alternative Names: T-2307

Latest Information Update: 28 Aug 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Toyama Chemical
  • Class Antifungals; Benzamidines; Piperidines; Small molecules
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase I Mycoses
  • Preclinical Aspergillosis; Candidiasis; Cryptococcosis

Most Recent Events

  • 31 Jul 2013 Phase-I development is ongoing in USA
  • 12 Sep 2012 Antimicrobial data from a preclinical study in Aspergillosis presented at the 52nd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC-2012)
  • 31 Jan 2010 Phase-I clinical trials in Mycoses (SC)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top